Fibronectin matrix assembly suppresses dispersal of glioblastoma cells

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Sabari, Joshua ^a   Lax, Daniel ^a   Connors, Daniel ^a   Brotman, Ian ^a   Mindrebo, Eric ^a   Butler, Christine ^a   Entersz, Ildiko ^a   Jia, Dongxuan ^a   Foty, Ramsey A ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; CADHERIN; DEXAMETHASONE; VERY LATE ACTIVATION ANTIGEN 5;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER GRADING; CELL AGGREGATION; CELL SPREADING; CONTROLLED STUDY; GLIOBLASTOMA; IN VITRO STUDY; PROTEIN ASSEMBLY; PROTEIN FUNCTION; BRAIN TUMOR; CELL MOTION; FLUORESCENCE MICROSCOPY; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; METHODOLOGY; MULTICELLULAR SPHEROID; REGRESSION ANALYSIS; STATISTICAL MODEL; TUMOR CELL LINE;

BRAIN NEOPLASMS; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; DEXAMETHASONE; FIBRONECTINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; INTEGRIN ALPHA5BETA1; MICROSCOPY, FLUORESCENCE; MODELS, STATISTICAL; REGRESSION ANALYSIS; SPHEROIDS, CELLULAR;

EID: 80053586675     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024810     Document Type: Article

References (46)

1. Smith JS, Jenkins RB, (2000) Genetic alterations in adult diffuse glioma: occurrence, significance, and prognostic implications. Front Biosci 5: D213-231.
2. Ohgaki H, Kleihues P, (2005) Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 64: 479-489.
3. Ohgaki H, Kleihues P, (2005) Epidemiology and etiology of gliomas. Acta Neuropathol 109: 93-108.
4. Brandes AA, Tosoni A, Franceschi E, Reni M, Gatta G, et al. (2008) Glioblastoma in adults. Crit Rev Oncol Hematol 67: 139-152.
5. Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, et al. (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95: 190-198.
6. Kogiku M, Ohsawa I, Matsumoto K, Sugisaki Y, Takahashi H, et al. (2008) Prognosis of glioma patients by combined immunostaining for survivin, Ki-67 and epidermal growth factor receptor. J Clin Neurosci 15: 1198-1203.
7. Riemenschneider MJ, Hegi ME, Reifenberger G, (2010) MGMT promoter methylation in malignant gliomas. Target Oncol 5: 161-165.
8. Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, et al. (2000) Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 343: 1350-1354.
9. Chamberlain MC, (2011) Radiographic patterns of relapse in glioblastoma. J Neurooncol 101: 319-323.
10. Clarke J, Butowski N, Chang S, (2010) Recent advances in therapy for glioblastoma. Arch Neurol 67: 279-283.
11. Li R, Li G, Deng L, Liu Q, Dai J, et al. (2010) IL-6 augments the invasiveness of U87MG human glioblastoma multiforme cells via up-regulation of MMP-2 and fascin-1. Oncol Rep 23: 1553-1559.
12. Knupfer MM, Poppenborg H, Van Gool S, Domula M, Wolff JE, (1997) Interferon-gamma inhibits proliferation and adhesion of T98G human malignant glioma cells in vitro. Klin Padiatr 209: 271-274.
13. George J, Banik NL, Ray SK, (2010) Knockdown of hTERT and concurrent treatment with interferon-gamma inhibited proliferation and invasion of human glioblastoma cell lines. Int J Biochem Cell Biol 42: 1164-1173.
14. Varga I, Hutoczki G, Petras M, Scholtz B, Miko E, et al. (2010) Expression of Invasion-Related Extracellular Matrix Molecules in Human Glioblastoma Versus Intracerebral Lung Adenocarcinoma Metastasis. Cen Eur Neurosurg 71: 173-180.
15. Hamel W, Westphal M, (2000) Growth factors in gliomas revisited. Acta Neurochir (Wien) 142: 113-137; discussion 137-118.
16. Hagemann C, Anacker J, Haas S, Riesner D, Schomig B, et al. (2010) Comparative expression pattern of Matrix-Metalloproteinases in human glioblastoma cell-lines and primary cultures. BMC Res Notes 3: 293.
17. Hegedus B, Marga F, Jakab K, Sharpe-Timms KL, Forgacs G, (2006) The interplay of cell-cell and cell-matrix interactions in the invasive properties of brain tumors. Biophys J 91: 2708-2716.
18. Jang HS, Lal S, Greenwood JA, (2010) Calpain 2 is required for glioblastoma cell invasion: regulation of matrix metalloproteinase 2. Neurochem Res 35: 1796-1804.
19. Foty RA, Steinberg MS, (1997) Measurement of tumor cell cohesion and suppression of invasion by E- or P-cadherin. Cancer Res 57: 5033-5036.
20. Foty RA, Corbett SA, Schwarzbauer JE, Steinberg MS, (1998) Dexamethasone up-regulates cadherin expression and cohesion of HT-1080 human fibrosarcoma cells. Cancer Res 58: 3586-3589.
21. Winters BS, Shepard SR, Foty RA, (2005) Biophysical measurement of brain tumor cohesion. Int J Cancer 114: 371-379.
22. Harris TJ, Tepass U, (2010) Adherens junctions: from molecules to morphogenesis. Nat Rev Mol Cell Biol 11: 502-514.
23. Mareel M, Leroy A, (2003) Clinical, cellular, and molecular aspects of cancer invasion. Physiol Rev 83: 337-376.
24. Cifarelli CP, Titus B, Yeoh HK, (2010) Cadherin-dependent adhesion of human U373MG glioblastoma cells promotes neurite outgrowth and increases migratory capacity. J Neurosurg.
25. McKeown-Longo PJ, Etzler CA, (1987) Induction of fibronectin matrix assembly in human fibrosarcoma cells by dexamethasone. J Cell Biol 104: 601-610.
26. Singh P, Carraher C, Schwarzbauer JE, (2010) Assembly of fibronectin extracellular matrix. Annu Rev Cell Dev Biol 26: 397-419.
27. Robinson EE, Zazzali KM, Corbett SA, Foty RA, (2003) alpha5beta1 integrin mediates strong tissue cohesion. J Cell Sci 116: 377-386.
28. Robinson EE, Foty RA, Corbett SA, (2004) Fibronectin matrix assembly regulates {alpha}5{beta}1-mediated cell cohesion. Mol Biol Cell 12: 12.
29. Yuan L, Holmes TC, Watts RE, Khosla C, Broekelmann TJ, et al. (2010) Novel chemo-sensitizing agent, ERW1227B, impairs cellular motility and enhances cell death in glioblastomas. J Neurooncol.
30. de Gennes P, (1994) Soft Interfaces Cambridge Cabridge University Press.
31. Corbett SA, Lee L, Wilson CL, Schwarzbauer JE, (1997) Covalent cross-linking of fibronectin to fibrin is required for maximal cell adhesion to a fibronectin-fibrin matrix. J Biol Chem 272: 24999-25005.
32. Sechler JL, Takada Y, Schwarzbauer JE, (1996) Altered rate of fibronectin matrix assembly by deletion of the first type III repeats. J Cell Biol 134: 573-583.
33. Ryan PL, Foty RA, Kohn J, Steinberg MS, (2001) Tissue spreading on implantable substrates is a competitive outcome of cell-cell vs. cell-substratum adhesivity. Proc Natl Acad Sci U S A 98: 4323-4327.
34. Nagane M, Lin H, Cavenee WK, Huang HJ, (2001) Aberrant receptor signaling in human malignant gliomas: mechanisms and therapeutic implications. Cancer Lett 162 (Suppl): S17-S21.
35. Brenner KA, Corbett SA, Schwarzbauer JE, (2000) Regulation of fibronectin matrix assembly by activated Ras in transformed cells. Oncogene 19: 3156-3163.
36. McKeown-Longo PJ, Mosher DF, (1985) Interaction of the 70,000-mol-wt amino-terminal fragment of fibronectin with the matrix-assembly receptor of fibroblasts. J Cell Biol 100: 364-374.
37. Fehlauer F, Muench M, Richter E, Rades D, (2007) The inhibition of proliferation and migration of glioma spheroids exposed to temozolomide is less than additive if combined with irradiation. Oncol Rep 17: 941-945.
38. Foty RA, Forgacs G, Pfleger CM, Steinberg MS, (1994) Liquid properties of embryonic tissues: Measurement of interfacial tensions. Physical Review Letters 72: 2298-2301.
39. Foty RA, Steinberg MS, (2004) Cadherin-mediated cell-cell adhesion and tissue segregation in relation to malignancy. Int J Dev Biol 48: 397-409.
40. Ponten J, Macintyre EH, (1968) Long term culture of normal and neoplastic human glia. Acta Pathol Microbiol Scand 74: 465-486.
41. Winters BS, Raj BK, Robinson EE, Foty RA, Corbett SA, (2006) Three-dimensional culture regulates Raf-1 expression to modulate fibronectin matrix assembly. Mol Biol Cell 17: 3386-3396.
42. Tabatabai G, Weller M, Nabors B, Picard M, Reardon D, et al. (2010) Targeting integrins in malignant glioma. Target Oncol 5: 175-181.
43. D'Abaco GM, Kaye AH, (2007) Integrins: molecular determinants of glioma invasion. J Clin Neurosci 14: 1041-1048.
44. Caicedo-Carvajal CE, Shinbrot T, Foty RA, (2010) Alpha5beta1 integrin-fibronectin interactions specify liquid to solid phase transition of 3D cellular aggregates. PLoS One 5: e11830.
45. Foty RA, Steinberg MS, (2005) The differential adhesion hypothesis: a direct evaluation. Dev Biol 278: 255-263.
46. Yuan L, Siegel M, Choi K, Khosla C, Miller CR, et al. (2007) Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy. Oncogene 26: 2563-2573.